Komori
Governance4591RIBOMIC Inc.Pharmaceuticals

Notice Concerning the Maximum Amount of Remuneration for Directors (Excluding Directors Who Are Audit and Supervisory Committee Members) and Directors Who Are Audit and Supervisory Committee Members

In connection with the transition to a Company with an Audit and Supervisory Committee, the Company will abolish the existing directors’ compensation framework and submit to the shareholders meeting a proposal setting annual compensation limits of ¥150 million or less for directors who are not Audit and Supervisory Committee Members, including ¥40 million or less for outside directors, and ¥30 million or less for directors who are Audit and Supervisory Committee Members.

Worth reading
70In focus
Scored from 1 of 5 sections
Direction
Neutral
Direction inferred from the company’s description.
Scale
30
¥ millions (annual compensation limit for directors who are Audit and Supervisory Committee Members)
Wording
Conditional
How definitive the wording is.

Governance structure

Company with an Audit and Supervisory Committee (planned transition)
Changes this time

In connection with the transition to a Company with an Audit and Supervisory Committee, the Company will abolish the current directors’ compensation framework and submit to the shareholders meeting a proposal setting the annual compensation limit at ¥150 million or less for directors who are not Audit and Supervisory Committee Members, including ¥40 million or less for outside directors, and at ¥30 million or less for directors who are Audit and Supervisory Committee Members.

Governance structure
ItemDetails
Corporate Governance StructureCompany with an Audit and Supervisory Committee (planned transition)
Changes this timeIn connection with the transition to a Company with an Audit and Supervisory Committee, the Company will abolish the current directors’ compensation framework and submit to the shareholders meeting a proposal setting the annual compensation limit at ¥150 million or less for directors who are not Audit and Supervisory Committee Members, including ¥40 million or less for outside directors, and at ¥30 million or less for directors who are Audit and Supervisory Committee Members.
Items this document does not state (6)
Number of directorsNumber of independent officersCommitteePolicy on cross-shareholdingsTakeover defensesControlling shareholder

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

In connection with the transition to a Company with an Audit and Supervisory Committee, to set compensation at a level appropriate to the responsibilities of directors who are Audit and Supervisory Committee Members. The Company also took comprehensive consideration of the responsibilities of Audit and Supervisory Committee Members, the scale of its business, and the need to respond flexibly to future demands for stronger governance.

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.
Notice Concerning the Maximum Amount of Remuneration for Directors (Excluding Directors Who Are Audit and Supervisory Committee Members) and Directors Who Are Audit and Supervisory Committee Members | RIBOMIC Inc. (4591) timely disclosure | Komori